Patients
We thus value patient outreach, for it never ceases to reignite our sense of urgency and validate our commitment to a strict pragmatism focused on real-world issues.
Most importantly, we also view patients as partners: they are indeed first-hand experts of their disease and primary stakeholders in the success of the medicinal enterprise.
At the same time, it is clear to us that we need to bring a drug to market if we are to bring it to patients.
Accordingly, we strongly believe that the most effective strategy to
achieve this commendable goal is to be organized as a for-profit,
reward-for-performance corporation, as we believe that an
individual’s drive for career development can effectively help
advance the global therapeutic enterprise.
Concurrently, our success thus demands that we operate along elementary
business rules, not the least of which is the scrupulous adherence to ethics, mutual candor and authenticity in all our dealings with all our partners, including customers, investors, employees and patients.
Additionally, we are committed to respect the strictest confidentiality over the content of these interactions.
|
